We are monitoring the impact of COVID-19 on Europe High Potency APIs (HPAPI) Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 2905
Share on
Share on

Europe High Potency APIs (HPAPI) Market Research Report – Segmented By Type, Synthesis, Therapeutic Application & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: August, 2019
ID: 2905
Pages: 145

Europe High Potency APIs (HPAPI) Market Size & Growth (2019 - 2024)

As per our analysis, the Europe High Potency APIs (HPAPI) Market size was valued at USD 5.32 billion in 2019 and estimated to be growing at a CAGR of 8.7%, to reach USD 8.07 billion by 2024 during the forecast period 2019-2024.

High Potency APIs (HPAPI) are pharmacological intermediates and substances which are active at concentrations of 150 micrograms per kilogram of body weight or below. They are very selective in nature, hence can bind to specific receptors or to specific enzymes which can cause cancer, developmental disorders, and reproductive problems at low doses. Since many new drugs have HPAPI’s the growth of this market is high.

High Potency APIs (HPAPI) have a wide range of applications for the treatment of many diseases of which cancer drugs are popular. After the mapping of the human genome, drugs for cancer could be made not only for different cancers but also for different patients. However, since these drugs are active at very low concentrations, they have to be manufactured with great care. They can pose health dangers to workers if proper care is not taken during production. Effective monitoring has to be done to prevent contamination of drugs with contaminants. So it requires specialized equipment for handling HPAPI’s and managing air quality.

The High Potency Active Pharmaceutical Ingredients market in Europe is driven by factors like their low price, rising healthcare prices growing number of pharmaceutical manufacturers, patients and increasing government initiatives to expand the usage of generic medicines to cut down healthcare costs.

However, the market is constrained by stringent regulatory requirements, the high price of equipment and lack of skilled workers.

This research report has been segmented and sub-segmented into the following categories:

  • By Type: Innovative HPAPI's and Generic HPAPI's.
  • By Synthesis: Biotech HPAPI's and Synthetic HPAPI's.
  • By Therapeutic Application: Oncology, Glaucoma and Hormonal Balance.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

There have been large investments in the Europe region for the HPAPI market in recent times. Factors such as rising incidence of cancer increased funding in cancer research and development of new drugs is expected to drive the market in this region.

Key companies in the Europe High Potency API (HPAPI) Market Profiled in the Report are Pfizer, Inc. (U.S.), Novartis International AG (Switzerland), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Boehringer Ingelheim (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (U.S.), AbbVie Inc. (U.S.), and Mylan Inc. (U.S.).

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Type                                              

                                5.1.1 Innovative HPAPI's                              

                                5.1.2 Generic HPAPI's                    

                                5.1.3  Y-o-Y Growth Analysis, By Type                    

                                5.1.4  Market Attractiveness Analysis, By Type                  

                                5.1.5  Market Share Analysis, By Type                    

                5.2 Synthesis                                     

                                5.2.1 Biotech HPAPI's                    

                                                5.2.1.1 Biotech High- otency Active Pharmaceutical Ingredients Market, By Type              

                                                                5.2.1.1.1 Innovative Biotech HPAPIs

                                                                5.2.1.1.2 Biosimilars

                                5.2.2 Synthetic HPAPI's                 

                                                5.2.2.1 Synthetic High Potency Active Pharmaceutical Ingredients Market, By Type          

                                                                5.2.2.1.1 Innovative Synthetic HPAPIs

                                                                5.2.2.1.2 Generic Synthetic HPAPIs

                                5.2.3 Y-o-Y Growth Analysis, By Synthesis                            

                                5.2.4 Market Attractiveness Analysis, By Synthesis                          

                                5.2.5 Market Share Analysis, By Synthesis                            

                5.3 Therapeutic Application                                        

                                5.3.1 Oncology                 

                                5.3.2 Glaucoma                

                                5.3.3 Hormonal Balance                

                                5.3.4 Other therapeutic applications                       

                                5.3.5 Y-o-Y Growth Analysis, By Therapeutic Application                               

                                5.3.6  Market Attractiveness Analysis, By Therapeutic Application                            

                                5.3.7  Market Share Analysis, By Therapeutic Application                              

                5.4 Manufacturer                                            

                                5.4.1 Captive Manufacturers                      

                                5.4.2 Merchant Manufacturers                 

                                                5.4.2.1 Merchant HPAPI Manufacturers Market, By Type             

                                                                5.4.2.1.1 Innovative Merchant HPAPI Manufacturers

                                                                5.4.2.1.2 Generic Merchant HPAPI Manufacturers

                                                5.4.2.2 Merchant HPAPI Manufacturers Market, By Type of Synthesis    

                                                                5.4.2.2.1 Synthetic HPAPIs

                                                                5.4.2.2.2 Biotech HPAPIs

                                5.4.3 Y-o-Y Growth Analysis, By Manufacturer                   

                                5.4.4  Market Attractiveness Analysis, By Manufacturer                

                                5.4.5  Market Share Analysis, By Manufacturer                  

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Type 

                                                6.1.3.2 By Synthesis       

                                                6.1.3.3 By Therapeutic Application           

                                                6.1.3.4 By Manufacturer              

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Type 

                                                6.1.4.2 By Synthesis       

                                                6.1.4.3 By Therapeutic Application           

                                                6.1.4.4  By Manufacturer             

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Type 

                                                6.1.5.2 By Synthesis       

                                                6.1.5.3 By Therapeutic Application           

                                                6.1.5.4 By Manufacturer              

                6.2 U.K                                 

                6.3 Spain                                             

                6.4 Germany                                     

                6.5 Italy                                               

                6.6 France                                          

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Pfizer Inc.                                    

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Novartis International AG                                    

                8.3 Sanofi                                           

                8.4 F. Hoffmann-La Roche Ltd.                                  

                8.5 Eli Lilly and Company                                              

                8.6 Bristol-Myers Squibb                                              

                8.7 Boehringer Ingelheim                                            

                8.8 Teva Pharmaceutical Industries Ltd.                                

                8.9 Merck & Co., Inc.                                     

                8.10 AbbVie Inc.                                              

                8.11 Mylan Inc.                                 

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe High Potency Active Pharmaceutical Ingredients Market By Type, From 2019-2024 ( USD Billion )
  2. Europe Innovative HPAPI's  Market By Region, From 2019-2024 ( USD Billion )
  3. Europe Generic HPAPI's Market By Region, From 2019-2024 ( USD Billion )
  4. Europe High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2019-2024 ( USD Billion )
  5. Europe Biotech HPAPI's Market By Region, From 2019-2024 ( USD Billion )
  6. Europe Synthetic HPAPI's Market By Region, From 2019-2024 ( USD Billion )
  7. Europe High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  8. Europe Oncology Market By Region, From 2019-2024 ( USD Billion )
  9. Europe Glaucoma Market By Region, From 2019-2024 ( USD Billion )
  10. Europe Hormonal Balance Market By Region, From 2019-2024 ( USD Billion )
  11. Europe other therapeutic applications Market By Region, From 2019-2024 ( USD Billion )
  12. U.K. High Potency Active Pharmaceutical Ingredients Market By Type, From 2019-2024 ( USD Billion )
  13. U.K. High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2019-2024 ( USD Billion )
  14. U.K. High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  15. Germany High Potency Active Pharmaceutical Ingredients Market By Type, From 2019-2024 ( USD Billion )
  16. Germany High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2019-2024 ( USD Billion )
  17. Germany High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  18. France High Potency Active Pharmaceutical Ingredients Market By Type, From 2019-2024 ( USD Billion )
  19. France High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2019-2024 ( USD Billion )
  20. France High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  21. Italy High Potency Active Pharmaceutical Ingredients Market By Type, From 2019-2024 ( USD Billion )
  22. Italy High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2019-2024 ( USD Billion )
  23. Italy High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2019-2024 ( USD Billion )
  24. Spain High Potency Active Pharmaceutical Ingredients Market By Type, From 2019-2024 ( USD Billion )
  25. Spain High Potency Active Pharmaceutical Ingredients Market By Synthesis, From 2019-2024 ( USD Billion )
  26. Spain High Potency Active Pharmaceutical Ingredients Market By Therapeutic Application, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample